
(E)-2-Pentene | CAS:646-04-8
(E)-2-Pentene
- 名称:(E)-2-戊烯 | (E)-2-Pentene
- CAS号:646-04-8
- 别名:2,5-Dihydroxyphenylacetic acid; Alcapton; Homogentisic acid; Homogentisinic acid; NSC 88940
- 分子式:C5H10
- 分子量:70.13
- EINESC号:211-461-4
产品描述
物理化学性质
熔点 | -138 ºC** |
---|---|
沸点 | 36.39 ºC (760 Torr)** |
闪点 | -45.6±0.0 ºC, 计算值* |
密度 | 0.65551 g/cm3 (15 ºC)** |
折射率 | 1.3899 (589.3 nm 5.3 ºC)** |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.M Arisawa et al.Antimicrobial agents and chemotherapy, 21(5), 706-710 (1982-05-01)
Genetic characterization and molecular cloning of the tripeptide permease (tpp) genes of Salmonella typhimurium.M M Gibson et al.Journal of bacteriology, 160(1), 122-130 (1984-10-01)
The fractional inhibitory concentration (FIC) index as a measure of synergy.M J Hall et al.The Journal of antimicrobial chemotherapy, 11(5), 427-433 (1983-05-01)
Antibacterial properties of alafosfalin combined with cephalexin.F R Atherton et al.Antimicrobial agents and chemotherapy, 20(4), 470-476 (1981-10-01)
Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.J G Allen et al.Antimicrobial agents and chemotherapy, 17(6), 973-979 (1980-06-01)
Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.P Angehrn et al.Antimicrobial agents and chemotherapy, 25(5), 607-611 (1984-05-01)
Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania.K J Towner et al.Bulletin of the World Health Organization, 58(5), 747-751 (1980-01-01)
Alafosfalin as a selective agent for isolation of salmonella from clinical samples.J D Perry et al.Journal of clinical microbiology, 40(11), 3913-3916 (2002-11-01)
Antibacterial activity of phosphono dipeptides related to alafosfalin.B Lejczak et al.Journal of medicinal chemistry, 29(11), 2212-2217 (1986-11-01)
Effect of food on the bioavailability of alafosfalin, a new antibacterial agent.P G Welling et al.The Journal of antimicrobial chemotherapy, 6(3), 373-379 (1980-05-01)
Phosphonopeptides, a new class of synthetic antibacterial agents.J G Allen et al.Nature, 272(5648), 56-58 (1978-03-02)
Penetration of alafosfalin and ampicillin into tissue cage fluid in rabbits.C Henning et al.Chemotherapy, 28(3), 185-188 (1982-01-01)
Recent developments in the field of phosphonic acid antibiotics.M Neuman The Journal of antimicrobial chemotherapy, 14(4), 309-311 (1984-10-01)
Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin.F R Atherton et al.Antimicrobial agents and chemotherapy, 15(5), 696-705 (1979-05-01)
Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.F R Atherton et al.Antimicrobial agents and chemotherapy, 18(6), 897-905 (1980-12-01)
Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria.S F Grappel et al.Antimicrobial agents and chemotherapy, 27(6), 961-963 (1985-06-01)
In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.W H Traub Chemotherapy, 26(2), 103-110 (1980-01-01)
Alafosfalin, a new synthetic antibacterial compound.F E Hahn Die Naturwissenschaften, 68(2), 90-90 (1981-02-01)
[Antibiotics of the phosphonic acid group].M S Poliak Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology, 32(1), 66-75 (1987-01-01)
Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.Jana Neumann et al.European journal of biochemistry, 271(10), 2012-2017 (2004-05-07)
Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid.F R Atherton et al.Journal of medicinal chemistry, 29(1), 29-40 (1986-01-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!